PainTEQ Receives Prestigious 'Deal of the Year' Award at Annual Tampa Bay Dealmaker Summit

PainTEQ Receives Honor at Tampa Bay Dealmaker Summit

On February 26th, 2026, PainTEQ, a frontrunner in minimally invasive solutions for sacroiliac (SI) joint stabilization, proudly received the 'VC/PE Deal of the Year' award at the Annual Tampa Bay Dealmaker Summit held at the prestigious Palma Ceia Golf and Country Club. This accolade is a testament to PainTEQ's impressive national deal profile, exceptional business trajectory, and the significant clinical impact it has made within the healthcare sector.

The Tampa Bay Dealmaker Summit is known as the Southeast's premier platform for celebrating innovative companies that are transforming Florida's business landscape. Having successfully navigated a recent majority growth recapitalization led by Windham Capital Partners and Signet Healthcare Partners, PainTEQ stands out for its strategic clarity and real-world impact.

David Kereiakes, Managing Partner at Windham Capital, emphasized that the recognition highlights the partnership's commitment to enhancing healthcare. He stated, "It confirms we aren't just investing in a company; we are backing a new standard of care." Likewise, Ashley Friedman, Managing Director at Signet Healthcare Partners, noted that winning against robust competition reinforces their dedication and the strength of PainTEQ's mission.

PainTEQ's CEO, Shanth Thiyagalingam, expressed that the honor signifies a shared vision to create a lasting solution for patients suffering from SI joint dysfunction. He commented, "This award represents our team’s relentless execution through uncertainty and the firm belief of globally recognized medical device investors in our LinQ therapy."

The LinQ SI Joint Stabilization System has been crucial in PainTEQ's rapid adoption within the medical community, earning the trust of physician partners who prioritize the therapy's proven clinical outcomes. The innovative implant and single-use instruments developed by PainTEQ aim to provide immediate benefits to individuals grappling with debilitating lower back pain through minimally invasive, outpatient procedures.

As a pioneer in addressing SI joint dysfunction, PainTEQ strives to improve patient outcomes by empowering pain management specialists. Through its significant contributions, the company is set to redefine care standards in the medical device field.

Raymond James served as financial advisor to PainTEQ for this landmark deal, providing essential insights and guidance throughout the process.

At PainTEQ, the vision remains clear: to bring transformative, interventional procedures to the market, enhancing the quality of life for those affected by lower back pain. Learn more about their innovative solutions by visiting www.painteq.com.

The Tampa Bay Dealmaker Summit, an initiative of the DealMaker Forum in partnership with the Lowth Entrepreneurship Center at the University of Tampa, continues to be a vital platform for recognizing and fostering excellence in regional entrepreneurship, venture capital, and corporate growth in Florida.

This recognition marks a pivotal moment in PainTEQ's journey, further establishing its position as a leader in healthcare innovation and commitment to patient-centered care.